US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study
Public ClinicalTrials.gov record NCT00515164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Study of the 20 mL Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema
Study identification
- NCT ID
- NCT00515164
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Aeris Therapeutics
- Industry
- Enrollment
- 22 participants
Conditions and interventions
Interventions
- Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Mar 31, 2008
- Completion
- Nov 30, 2009
- Last update posted
- Oct 23, 2011
2007 – 2009
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pulmonary Associates | Phoenix | Arizona | 85006 | — |
| University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242 | — |
| Veritas Clinical Specialties, Ltd | Topeka | Kansas | 66606 | — |
| St Joseph's Medical Center | Towson | Maryland | 21204 | — |
| Akron Medical Center | Akron | Ohio | 44302 | — |
| Pulmonary, Allergy & Critical Care Medicine, Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Temple University Lung Center | Philadelphia | Pennsylvania | 19140 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00515164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2011 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00515164 live on ClinicalTrials.gov.